This proposal seeks to develop statistical methods for medical diagnostic testing and disease screening which will allow a greater range of study designs to be used and a greater range of research questions to be addressed than can be done at present. There are four aims: 1. To develop regression modeling methods for sensitivity and specificity for dichotomous tests. 2. Robust estimation, comparison and optimization of receiver operating characteristic (ROC) curves. 3. For continuous tests,analogous regression modeling methods are proposed for ROC curves. Recently developed marginal regression modeling methods will be applied and modified as necessary. Regression modeling methodology can take account of factors which influence test accuracy as well for comparing different diagnostic tests. Marginal regression methods will accommodate clustered and unbalanced data which frequently arise in studies to evaluate diagnostic tests. 4. In the event that disease status may be unknown for a subset of study subjects, especially in screening studies, it is proposed to apply some missing data techniques to permit valid inference in such settings. In order to evaluate the proposed methodologies, each aim will require the following three steps: 1) development of large sample theory; 2) small sample simulation studies; and 3) application to real data. Four real data sets are available for this project and will guide the development of, and illustrate, the new methodologies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM054438-03
Application #
2701763
Study Section
Special Emphasis Panel (ZRG7-STA (01))
Project Start
1996-05-01
Project End
1999-08-31
Budget Start
1998-05-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Kerr, Kathleen F; Brown, Marshall; Janes, Holly (2017) Reply to A.J. Vickers et al. J Clin Oncol 35:473-475
Kim, Soyoung; Huang, Ying (2017) Combining biomarkers for classification with covariate adjustment. Stat Med 36:2347-2362
Kerr, Kathleen F; Brown, Marshall D; Zhu, Kehao et al. (2016) Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use. J Clin Oncol 34:2534-40
Fong, Youyi; Yin, Shuxin; Huang, Ying (2016) Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve. Stat Med 35:3792-809
Pepe, Margaret S; Janes, Holly; Li, Christopher I et al. (2016) Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? Clin Chem 62:737-42
Huang, Ying (2016) Evaluating and comparing biomarkers with respect to the area under the receiver operating characteristics curve in two-phase case-control studies. Biostatistics 17:499-522
Huang, Ying; Laber, Eric (2016) Personalized Evaluation of Biomarker Value: A Cost-Benefit Perspective. Stat Biosci 8:43-65
Pepe, Margaret Sullivan (2015) Response. J Natl Cancer Inst 107:356
Pepe, Margaret S; Fan, Jing; Feng, Ziding et al. (2015) The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets. Stat Biosci 7:282-295
Pepe, Margaret S; Li, Christopher I; Feng, Ziding (2015) Improving the quality of biomarker discovery research: the right samples and enough of them. Cancer Epidemiol Biomarkers Prev 24:944-50

Showing the most recent 10 out of 74 publications